Real-World Multicenter Registry of Patients with Severe Coronary Artery Calcification Undergoing Orbital Atherectomy
Michael S Lee, Evan Shlofmitz, Barry Kaplan, Dragos Alexandru, Perwaiz Meraj, Richard Shlofmitz, Michael S Lee, Evan Shlofmitz, Barry Kaplan, Dragos Alexandru, Perwaiz Meraj, Richard Shlofmitz
Abstract
Objectives: We evaluated the safety and efficacy of orbital atherectomy in real-world patients with severe coronary artery calcification (CAC).
Background: The presence of severe CAC increases the complexity of percutaneous coronary intervention as it may impede stent delivery and optimal stent expansion. Atherectomy may be an indispensable tool for uncrossable or undilatable lesions by modifying severe CAC. Although the ORBIT I and II trials report that orbital atherectomy was safe and effective for the treatment of severe CAC, patients with kidney disease, recent myocardial infarction, long diffuse disease, severe left ventricular dysfunction, and unprotected left main disease were excluded.
Methods: This retrospective study included 458 consecutive patients with severe CAC who underwent orbital atherectomy followed by stenting from October 2013 to December 2015 at 3 centers.
Results: The primary endpoint of major adverse cardiac and cerebrovascular events at 30 days was 1.7%. Low rates of 30-day all-cause mortality (1.3%), myocardial infarction (1.1%), target vessel revascularization (0%), stroke (0.2%), and stent thrombosis (0.9%) were observed. Angiographic complications were low: perforation was 0.7%, dissection 0.9%, and no-reflow 0.7%. Emergency coronary artery bypass graft surgery was performed in 0.2% of patients.
Conclusion: In the largest real-world study of patients who underwent orbital atherectomy, including high-risk patients who were not surgical candidates as well as those with very complex coronary anatomy, acute and short-term adverse clinical event rates were low. A randomized clinical trial is needed to identify the ideal treatment strategy for patients with severe CAC.
© 2016 The Authors. Journal of Interventional Cardiology Published by Wiley Periodicals, Inc.
References
- Goel R, Garg P, Achenbach S, et al. Coronary artery calcification and coronary atherosclerotic disease. Cardiol Clin 2012; 30:19–47.
- Lee MS, Yang T, Lasala J, et al. Impact of coronary artery calcification in percutaneous coronary intervention with paclitaxel‐eluting stents: Two‐year clinical outcomes of paclitaxel‐eluting stents in patients from the ARRIVE program. Catheter Cardiovasc Interv Jan 2016. doi:
- MacIsaac AI, Bass TA, Buchbinder M, et al. High speed rotational atherectomy: Outcome in calcified and noncalcified coronary artery lesions. J Am Coll Cardiol 1995; 26:731–736.
- Kiesz RS, Rozek MM, Ebersole DG, et al. Novel approach to rotational atherectomy results in low restenosis rates in long, calcified lesions: Long‐term results of the San Antonio Rotablator Study (SARS). Catheter Cardiovasc Interv 1999; 48:48–53.
- Tran T, Brown M, Lasala J. An evidence‐based approach to the use of rotational and directional coronary atherectomy in the era of drug‐eluting stents: When does it make sense? Catheter Cardiovasc Interv 2008; 72:650–662.
- Whitbourn RJ, Sethi R, Pomerantsev EV, et al. High‐speed rotational atherectomy and coronary stenting: QCA and QCU analysis. Catheter Cardiovasc Interv 2003; 60:167–171.
- Henneke KH, Regar E, Konig A, et al. Impact of target lesion calcification on coronary stent expansion after rotational atherectomy. Am Heart J 1999; 137:93–99.
- Hoffmann R, Mintz GS, Popma JJ, et al. Treatment of calcified coronary lesions with Palmaz‐Schatz stents. An intravascular ultrasound study. Eur Heart J 1998; 19:1224–1231.
- Hoffmann R, Mintz GS, Kent KM, et al. Comparative early and nine‐month results of rotational atherectomy, stents, and the combination of both for calcified lesions in large coronary arteries. Am J Cardiol 1998; 81:552–557.
- Chambers JW, Feldman RL, Himmelstein SI, et al. Pivotal trial to evaluate the safety and efficacy of the orbital atherectomy system in treating de novo, severely calcified coronary lesions (ORBIT II). JACC Cardiovasc Interv 2014; 7:510–518.
- Généreux P, Lee AC, Kim CY, et al. Orbital atherectomy for treating de novo severely calcified coronary narrowing (1‐year results from the pivotal ORBIT II trial). Am J Cardiol 2015; 115:1685–1690.
- Généreux P., Bettinger N., Redfors B., et al. Two‐year outcomes after treatment of severely calcified coronary lesions with the orbital atherectomy system and the impact of stent types: Insights from the ORBIT II trial. Catheter Cardiovasc Interv 2016. doi:
- Cutlip DE, Windecker S, Mehran R, et al. Academic research consortium. Clinical end points in coronary stent trials: A case for standardized definitions Circulation 2007; 115:2344–2351.
- Abdel‐Wahab M, Richardt G, Joachim Buttner H, et al. High‐speed rotational atherectomy before paclitaxel‐eluting stent implantation in complex calcified coronary lesions: The randomized ROTAXUS (Rotational Atherectomy Prior to Taxus Stent Treatment for Complex Native Coronary Artery Disease) trial. JACC Cardiovasc Interv 2013; 6:10–19.
- Kuriyama N, Kobayashi Y, Yamaguchi M, et al. Usefulness of rotational atherectomy in preventing polymer damage of everolimus eluting stent in calcified coronary artery. J Am Coll Cardiol Intv 2011; 4:588–589.
- Levine GN, Bates ER, Blankenship JC, et al. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 2011; 58:e44–e122.
- Ramana RK, Joyal D, Arab D, et al. Clinical experience with rotational atherectomy in patients with severe left ventricular dysfunction. J Invasive Cardiol 2006; 18:514–518.
- Parikh K, Chandra P, Choksi N, et al. Safety and feasibility of orbital atherectomy for the treatment of calcified coronary lesions: The ORBIT I trial. Catheter Cardiovasc Interv 2013; 81:1134–1139.
Source: PubMed